- Consumer Products
- Latest 64.39
- Currency US$
- Change -1.84
- Percent Change -2.778 %
- Volume 1,200,633
- Wed Dec 11, 2013 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Oct 29||$-0.39||Feb 4||$-0.62|
12 months ended Dec 12, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)